SLEEP 2011 Abstract Supplement
SLEEP 2011 Abstract Supplement
SLEEP 2011 Abstract Supplement
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
B. Clinical Sleep Science XIII. Sleep and Gender<br />
4-7 months, we hypothesized that significant levels of sleep disturbance<br />
and fatigue would exist and that sleep disturbance and fatigue would be<br />
positively associated with two measures of emotional status: depression<br />
and parenting hassles.<br />
Methods: Twenty-three mothers (M age=31.18 ± 3.86 years) of infants<br />
(M age=5.22 ± .86 months) completed self-report measures assessing<br />
fatigue (IFS), depressive symptoms (CES-D) and parenting hassles<br />
(Parenting Daily Hassles Scale; PDH). Additionally, participants recorded<br />
their sleep for one week using actigraphy and sleep diaries. Nonparametric<br />
correlations were calculated to test associations between<br />
variables.<br />
Results: Average total nightly sleep time was 6 hours, 57 minutes and<br />
average wake after sleep onset was 49 minutes; 61% reported clinically<br />
significant symptoms of fatigue (IFS>30). Non-parametric correlations<br />
revealed that fatigue was associated with depressive symptoms (.622,<br />
p=.002). Less 24-hour total sleep time was associated with greater parenting<br />
hassles (-.414, p=.055). Actigraph-derived sleep characteristics<br />
and fatigue were not associated with frequency of infant night-time waking<br />
(crying) or infant sleep onset latency.<br />
Conclusion: High levels of maternal fatigue persist after the newborn<br />
phase; fatigue is also a robust indicator of depressive symptoms. As both<br />
depression and parenting hassles are related to sleep measures and can<br />
impair mother-infant relationship quality, assessment of maternal sleep<br />
and fatigue beyond the newborn period is warranted. From a public<br />
health perspective, these findings are particularly relevant as this agerange<br />
captures the stage when mothers are returning to work, requiring<br />
adaptation within the mother-infant relationship while also creating<br />
changes in sleep schedules and routines.<br />
Support (If Any): Dr. Ronzio received support from the Research Advisory<br />
Council, Children’s National Medical Center.<br />
0939<br />
COMPARISON OF LABORATORY POLYSOMNOGRAPHY<br />
AND AN AMBULATORY <strong>SLEEP</strong> APNEA MONITOR FOR<br />
DETECTING OBSTRUCTIVE <strong>SLEEP</strong> APNEA IN PREGNANT<br />
WOMEN<br />
Sharkey KM 1,2,4 , Millman RP 1,4 , Bourjeily G 1,3<br />
1<br />
Medicine, Alpert Medical School of Brown University, Providence,<br />
RI, USA, 2 Psychiatry & Human Behavior, Alpert Medical School of<br />
Brown University, Providence, RI, USA, 3 Medicine, Women & Infants<br />
Hospital, Providence, RI, USA, 4 Medicine, Rhode Island Hospital,<br />
Providence, RI, USA<br />
Introduction: The purpose of this study was to validate a portable<br />
recorder, the Apnea Risk Evaluation System (ARES) Unicorder (Watermark<br />
Medical, FL), with polysomnography (PSG) for detecting<br />
obstructive sleep apnea (OSA) in pregnancy. The ARES is validated<br />
in non-pregnant adults, but we hypothesized that facial edema during<br />
pregnancy could affect ARES oximetry and change performance of the<br />
device in pregnant women<br />
Methods: We recruited pregnant patients referred for a sleep study for<br />
clinical suspicion of OSA. PSG was scored using standard criteria to determine<br />
PSG apnea/hypopnea index (AHI). ARES data were processed<br />
using ARES software, which applies automated algorithms to identify<br />
SaO2 changes, pulse rate, head movements, and snoring and combines<br />
these factors to calculate an ARES AHI. We examined ARES AHI determined<br />
with 4% and 3% desaturations. We used AHI≥5 events/hour as<br />
the cutoff for OSA diagnosis for all methods. We computed sensitivity,<br />
specificity, and Kappa coefficients to assess diagnostic consistency between<br />
PSG and ARES.<br />
Results: Fifteen women (mean age±SD = 29.6+5.5 years; mean gestational<br />
age = 29.1±6.3 weeks, range= 17 to 38 weeks; mean BMI 44.8±7.3<br />
kg/m 2 , range=30.3 to 61.2 kg/m 2 ) had concurrent data collection with the<br />
ARES Unicorder and laboratory PSG. Eight women had OSA diagnosed<br />
with PSG: AHI range=6.8 to 113 events/hour. The ARES AHI 4% algorithm<br />
had sensitivity=0.63, specificity=1.0, and Kappa=0.61, p=.01. The<br />
ARES AHI 3% algorithm had sensitivity=0.75, specificity=0.71, and<br />
Kappa=.46, p=.07. Two patients with PSG AHIs of 8.4 and 8.9 events/<br />
hour were not identified with either ARES algorithm.<br />
Conclusion: The ARES Unicorder demonstrated reasonable consistency<br />
with PSG in this small, heterogeneous sample of pregnant women.<br />
The ARES algorithm with higher sensitivity (ARES AHI 3%) should be<br />
utilized in pregnancy because of potential adverse maternal and neonatal<br />
outcomes associated with untreated sleep-disordered breathing.<br />
Support (If Any): ARES Unicorders provided to GB by Advanced<br />
Brain Monitoring, Inc.<br />
0940<br />
<strong>SLEEP</strong> TIMING DURING POSTPARTUM WEEKS 1 AND 7<br />
Donie SK 1,2 , Claffey DJ 1,2 , Stone KC 1,2<br />
1<br />
Women & Infants Hospital, Providence, RI, USA, 2 The Warren Alpert<br />
Medical School of Brown University, Providence, RI, USA<br />
Introduction: Prior research has linked postpartum sleep duration and<br />
fragmentation to poor daytime outcomes. In the general population,<br />
sleep schedule variability and circadian shifting have also been linked to<br />
poor daytime functioning, but have not been investigated in postpartum<br />
women. This study investigates how postpartum women’s sleep schedules<br />
vary, if women are more likely to extend their total sleep time by<br />
advancing their bedtime or delaying their final morning wake time, and<br />
if these behaviors increase total sleep time.<br />
Methods: Participants included 10 postpartum mothers (M = 23.1<br />
years; 70% unmarried; 80% multiparous; 100% low SES) with a history<br />
of smoking who were participating in an intervention to remain smokefree.<br />
Actigraphic data corroborated by sleep diaries from postpartum<br />
weeks 1 and 7 were used to measure sleep onset/offset and nocturnal<br />
total sleep time. Standard deviations were used to measure variability of<br />
sleep start and end times.<br />
Results: Variability of sleep start time was negatively correlated with<br />
nocturnal total sleep time: (r = -.511, p = .025). Women were more likely<br />
to extend their total sleep time by waking after 8 am (53.3%) than by<br />
going to sleep before 11 pm (19.7%). Participants significantly increased<br />
their sleep duration by either going to sleep before 11 pm or waking after<br />
8 am (M = 367.67 min, SD = 107.14) or by doing both (M = 520 min,<br />
SD = 82.45) as compared to women who did neither (M = 299.23 min,<br />
SD = 80.83): F (121) = 28.1, p < .001.<br />
Conclusion: This study documents late bedtimes (M = 12:02 am) and<br />
wake times (M = 8:17 am) for mothers in the first seven weeks postpartum,<br />
which may represent a shift from pre-pregnancy sleep schedules.<br />
Future studies should investigate a possible early postpartum circadian<br />
shift and whether poor daytime outcomes result from such a shift.<br />
Support (If Any): NIH-NIDA R21DA026448<br />
0941<br />
SDB IS ASSOCIATED WITH AN INCREASED RISK OF<br />
ADVERSE PREGNANCY OUTCOMES<br />
Facco F 1 , Ouyang D 2 , Grobman W 1 , Kick A 1 , Stewart N 2 , Adams MG 2 ,<br />
Zee P 3<br />
1<br />
Obstetrics and Gynecology, Northwestern University, Chicago, IL,<br />
USA, 2 Obstetrics and Gynecology, NorthShore University Health<br />
System, Evanston, IL, USA, 3 Neurology, Northwestern University,<br />
Chicago, IL, USA<br />
Introduction: The term sleep-disordered breathing (SDB) describes<br />
a group of disorders characterized by abnormal respiratory patterns or<br />
quality of ventilation during sleep, resulting in hypoxia and nocturnal<br />
arousals. In non-pregnant populations SDB has been associated with<br />
cardiovascular and metabolic morbidities and mortality. Few studies<br />
have examined the relationship between SBD in pregnancy and adverse<br />
obstetrical outcomes. The objective of this study was to examine the association<br />
between SDB and adverse pregnancy outcomes (APO).<br />
A321<br />
<strong>SLEEP</strong>, Volume 34, <strong>Abstract</strong> <strong>Supplement</strong>, <strong>2011</strong>